Anouk Schrantee

Anouk Schrantee

Auto-generated profile, based on publicly available information

Anouk Schrantee

Centre for Urban Mental Health, University of Amsterdam, Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in American Journal of Psychiatry
Verified
Journal Article
Closed access
MHMartine Hoogman
Martine Hoogman
RMRyan Muetzel
Ryan Muetzel
JGJoao P. Guimaraes
Joao P. Guimaraes
ESElena Shumskaya
Elena Shumskaya
MMMaarten Mennes
Maarten Mennes
BFBarbara Franke
Barbara Franke

18 May 2020 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
LHLaura K. M. Han
Laura K. M. Han
RDRichard Dinga
Richard Dinga
THTim Hahn
Tim Hahn
CCChristopher R. K. Ching
Christopher R. K. Ching
LELisa T Eyler
Lisa T Eyler
LSLianne Schmaal
Lianne Schmaal
Major depressive disorder (MDD) is associated with an increased risk of brain atrophy, aging-related diseases, and mortality. We examined potential advanced brain aging in adult MDD patients, and whether this process is associated with clinical characteristics in a large multicenter international dataset. We performed a mega-analysis by pooling brain measures derived from T1-weighted MRI scans from 19 samples worldwide. Healthy brain aging was estimated by predicting chronological age (18–75 years) from 7 subcortical volumes, 34 cortical thickness and 34 surface area, lateral ventricles and total intracranial volume measures separately in 952 male and 1236 female controls from the ENIGMA MDD working group. The learned model coefficients were applied to 927 male controls and 986 depressed males, and 1199 female controls and 1689 depressed females to obtain independent unbiased brain-based age predictions. The difference between predicted “brain age” and chronological age was calculated to indicate brain-predicted age difference (brain-PAD). On average, MDD patients showed a higher brain-PAD of +1.08 (SE 0.22) years (Cohen’s d = 0.14, 95% CI: 0.08–0.20) compared with controls. However, this difference did not seem to be driven by specific clinical characteristics (recurrent status, remission status, antidepressant medication use, age of onset, or symptom severity). This highly powered collaborative effort showed subtle patterns of age-related structural brain abnormalities in MDD. Substantial within-group variance and overlap between groups were observed. Longitudinal studies of MDD and somatic health outcomes are needed to further assess the clinical value of these brain-PAD estimates.

29 May 2020 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
LSLianne Schmaal
Lianne Schmaal
EPElena Pozzi
Elena Pozzi
THTiffany C. Ho
Tiffany C. Ho
LVLaura S. van Velzen
Laura S. van Velzen
IVIlya M. Veer
Ilya M. Veer
DVDick J. Veltman
Dick J. Veltman
A key objective in the field of translational psychiatry over the past few decades has been to identify the brain correlates of major depressive disorder (MDD). Identifying measurable indicators of brain processes associated with MDD could facilitate the detection of individuals at risk, and the development of novel treatments, the monitoring of treatment effects, and predicting who might benefit most from treatments that target specific brain mechanisms. However, despite intensive neuroimaging research towards this effort, underpowered studies and a lack of reproducible findings have hindered progress. Here, we discuss the work of the ENIGMA Major Depressive Disorder (MDD) Consortium, which was established to address issues of poor replication, unreliable results, and overestimation of effect sizes in previous studies. The ENIGMA MDD Consortium currently includes data from 45 MDD study cohorts from 14 countries across six continents. The primary aim of ENIGMA MDD is to identify structural and functional brain alterations associated with MDD that can be reliably detected and replicated across cohorts worldwide. A secondary goal is to investigate how demographic, genetic, clinical, psychological, and environmental factors affect these associations. In this review, we summarize findings of the ENIGMA MDD disease working group to date and discuss future directions. We also highlight the challenges and benefits of large-scale data sharing for mental health research.

16 June 2020 in American Journal of Psychiatry
Verified
Journal Article
Closed access
PBPremika S.W. Boedhoe
Premika S.W. Boedhoe
DRDaan van Rooij
Daan van Rooij
MHMartine Hoogman
Martine Hoogman
JTJos W.R. Twisk
Jos W.R. Twisk
LSLianne Schmaal
Lianne Schmaal
OHOdile A. van Den Heuvel
Odile A. van Den Heuvel

28 May 2020 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
NONils Opel
Nils Opel
Anbupalam ThalamuthuAnbupalam Thalamuthu
Anbupalam Thalamuthu
YMYuri Milaneschi
Yuri Milaneschi
DGDominik Grotegerd
Dominik Grotegerd
CFClaas Flint
Claas Flint
UDUdo Dannlowski
Udo Dannlowski
Emerging evidence suggests that obesity impacts brain physiology at multiple levels. Here we aimed to clarify the relationship between obesity and brain structure using structural MRI (n = 6420) and genetic data (n = 3907) from the ENIGMA Major Depressive Disorder (MDD) working group. Obesity (BMI > 30) was significantly associated with cortical and subcortical abnormalities in both mass-univariate and multivariate pattern recognition analyses independent of MDD diagnosis. The most pronounced effects were found for associations between obesity and lower temporo-frontal cortical thickness (maximum Cohen´sd(left fusiform gyrus) = −0.33). The observed regional distribution and effect size of cortical thickness reductions in obesity revealed considerable similarities with corresponding patterns of lower cortical thickness in previously published studies of neuropsychiatric disorders. A higher polygenic risk score for obesity significantly correlated with lower occipital surface area. In addition, a significant age-by-obesity interaction on cortical thickness emerged driven by lower thickness in older participants. Our findings suggest a neurobiological interaction between obesity and brain structure under physiological and pathological brain conditions.

1 October 2020 in NeuroImage
Verified
Journal Article
Open access
HMHenk Mutsaerts
Henk Mutsaerts
JPJan Petr
Jan Petr
PGPaul Groot
Paul Groot
PVPieter Vandemaele
Pieter Vandemaele
SISilvia Ingala
Silvia Ingala
FBFrederik Barkhof
Frederik Barkhof
Arterial spin labeling (ASL) has undergone significant development since its inception, with a focus on improving standardization and reproducibility of its acquisition and quantification. In a community-wide effort towards robust and reproducible clinical ASL image processing, we developed the software package ExploreASL, allowing standardized analyses across centers and scanners. The procedures used in ExploreASL capitalize on published image processing advancements and address the challenges of multi-center datasets with scanner-specific processing and artifact reduction to limit patient exclusion. ExploreASL is self-contained, written in MATLAB and based on Statistical Parameter Mapping (SPM) and runs on multiple operating systems. To facilitate collaboration and data-exchange, the toolbox follows several standards and recommendations for data structure, provenance, and best analysis practice. ExploreASL was iteratively refined and tested in the analysis of >10,000 ASL scans using different pulse-sequences in a variety of clinical populations, resulting in four processing modules: Import, Structural, ASL, and Population that perform tasks, respectively, for data curation, structural and ASL image processing and quality control, and finally preparing the results for statistical analyses on both single-subject and group level. We illustrate ExploreASL processing results from three cohorts: perinatally HIV-infected children, healthy adults, and elderly at risk for neurodegenerative disease. We show the reproducibility for each cohort when processed at different centers with different operating systems and MATLAB versions, and its effects on the quantification of gray matter cerebral blood flow. ExploreASL facilitates the standardization of image processing and quality control, allowing the pooling of cohorts which may increase statistical power and discover between-group perfusion differences. Ultimately, this workflow may advance ASL for wider adoption in clinical studies, trials, and practice.